ArticleClinical ophthalmology (Auckland, N.Z.)2026
The Association of Vertically Integrated Delivery Networks on Lapses in Diabetic Retinopathy Care and Presenting Diabetic Retinopathy Severity.
Article in Clinical ophthalmology (Auckland, N.Z.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Vertical integration of ophthalmologists with primary care providers (PCP) may improve diabetic retinopathy (DR) by reducing lapses in care and promoting early detection. We examine how PCP integration impacts DR outcomes, and whether that relationship is affected by the distance patients live from the health system. Methods: This retrospective cohort study included adults (≥18 years) with diabetes mellitus seen at the Wilmer Eye Institute from April 2013 to September 2023. The primary exposure was PCP type, classified as internal (within the Johns Hopkins Health System Corporation) or external. To assess whether PCP integration effects varied by distance, an interaction term with distance to clinic (≤7.6 vs. >7.6 miles) was included. The primary outcome was lapse in care, or not returning as recommended. Secondary outcomes, defined at the initial DR screening visit, were vision impairment, blindness, visual acuity (in logMAR), and DR severity. Multivariable regression models adjusted for age, race, insurance, comorbidities, and ocular disease. Results: A total of 41,581 patients were included, and 81% had at least one lapse in care in two years. For lapses in care, having an external PCP, compared to internal, was associated with a 19% higher odds of a lapse but only for patients who lived >7.6 miles away. Having an external PCP was also associated with more severe disease at presentation regardless of the distance patients lived from the clinic, including: higher odds of vision impairment, blindness, worse visual acuity, higher DR severity. Conclusion: Patients with external PCPs, particularly those living farther from the clinic, experienced higher odds of lapses in DR care and presented with more severe eye disease. These patients may benefit from targeted care coordination or outreach to support adherence and earlier referrals for DR.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.